Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial

Seizure

Volumn 31, Issue , 2015, Pages 72-79

  Zadeh, Wendy Waldman ^a   Escartin, Antonio ^b   Byrnes, William ^c   Tennigkeit, Frank ^c   Borghs, Simon ^c   Li, Ting ^c   Dedeken, Peter ^c   De Backer, Marc ^c  

^a BROADLAWNS MEDICAL CENTER   (United States)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UCB PHARMA   (Belgium)

Author keywords

Focal epilepsy; Lacosamide; Quality of life; Seizure freedom

Indexed keywords

HARKOSERIDE; ACETAMIDE DERIVATIVE; ANTICONVULSIVE AGENT;

ADD ON THERAPY; ADULT; AGED; AGRANULOCYTOSIS; ANTICONVULSANT THERAPY; ANXIETY DISORDER; ARTICLE; BLURRED VISION; COHORT ANALYSIS; CONVULSION; DEPRESSION; DIPLOPIA; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FEVER; FOCAL EPILEPSY; HEADACHE; HUMAN; INFLUENZA; IRRITABILITY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; OPEN STUDY; PHASE 3 CLINICAL TRIAL; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RHINOPHARYNGITIS; SOMNOLENCE; TREATMENT DURATION; TREMOR; VERTIGO; ADOLESCENT; CLINICAL TRIAL; COMBINATION DRUG THERAPY; MIDDLE AGED; PROSPECTIVE STUDY; SEIZURES; TREATMENT OUTCOME; YOUNG ADULT;

ACETAMIDES; ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEIZURES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84941129549     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2015.07.001     Document Type: Article

References (23)

1. P. Kwan, and M.J. Brodie Early identification of refractory epilepsy The New England Journal of Medicine 342 2000 314 319
2. ® (lacosamide tablets, injection, oral solution) [U.S. prescribing information]. Smyrna: UCB, Inc. http://www.vimpat.com/pdf/vimpat-PI.pdf. Last updated February 2015.
3. ® (lacosamide) EMA Summary of Product Characteristics http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Product-Information/human/000863/WC500050338.pdf. Last updated January 2015.
4. E. Ben-Menachem, V. Biton, D. Jatuzis, B. Abou-Khalil, P. Doty, and G.D. Rudd Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures Epilepsia 48 2007 1308 1317
5. S. Chung, M.R. Sperling, V. Biton, G. Krauss, D. Hebert, G.D. Rudd, and et al. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial Epilepsia 51 2010 958 967
6. P. Halasz, R. Kalviainen, M. Mazurkiewicz-Beldzinska, F. Rosenow, P. Doty, D. Hebert, and et al. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial Epilepsia 50 2009 443 453
7. S. Chung, E. Ben-Menachem, M.R. Sperling, W. Rosenfeld, N.B. Fountain, S. Benbadis, and et al. Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials CNS Drugs 24 2010 1041 1054
8. M.J. Brodie, S.J. Barry, G.A. Bamagous, J.D. Norrie, and P. Kwan Patterns of treatment response in newly diagnosed epilepsy Neurology 78 2012 1548 1554
9. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Guidance for Industry. E6 Good Clinical Practice: Consolidated Guidance. http://www.ich.org/products/guidelines/efficacy/efficacy-single/article/good-clinical-practice.html. Last updated June 1996.
10. J.A. Cramer, and G. Van Hammee Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam Epilepsy Behavior 4 2003 118 123
11. S. Borghs, C. de la Loge, and J.A. Cramer Defining minimally important change in QOLIE-31 scores: estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures Epilepsy Behavior 23 2012 230 234
12. P. Kwan, A. Arzimanoglou, A.T. Berg, M.J. Brodie, W. Allen Hauser, G. Mathern, and et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies Epilepsia 51 2010 1069 1077
13. M. Noack-Rink, V. Irrgang, F. Ramirez, T. Mayer, S. Arnold, and U. Runge Lacosamide added to a monotherapy in epilepsy patients with partial-onset seizures: final analysis of the VITOBA study Epilepsia 55 Suppl. 2 2014 114 [abstract]
14. V. Villanueva, F.J. Lopez, J.M. Serratosa, B. Gonzalez-Giraldez, D. Campos, A. Molins, and et al. Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide Epilepsy Behavior 29 2013 349 356
15. M.J. Brodie, K. Kelly, and L.J. Stephen Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses? Epilepsy Behavior 31 2014 73 76
16. Y. Schiller, and Y. Najjar Quantifying the response to antiepileptic drugs: effect of past treatment history Neurology 70 2008 54 65
17. V. Villanueva, M. Garces, E. Lopez-Gomariz, J.M. Serratosa, B. Gonzalez-Giraldez, J. Parra, and et al. Early add-on lacosamide in a real-life setting: results of the REALLY study Clinical Drug Investigation 35 2015 121 131
18. C. de la Loge, J.A. Cramer, S. Borghs, A. Eggert, and P. Doty Improvement in patient-reported outcomes seen in patients responding to lacosamide: pooled QOLIE-31, SSS and PGIC data from 3 phase II/III clinical trials Epilepsia 50 Suppl. 10 2009 113 [abstract]
19. C. Schaefer, W. Cawello, J. Waitzinger, and J.P. Elshoff Effect of age and sex on lacosamide pharmacokinetics in healthy adult subjects and adults with focal epilepsy Clinical Drug Investigation 35 2015 255 265
20. L.J. Stephen, K. Kelly, P. Parker, and M.J. Brodie Adjunctive lacosamide - 5 years' clinical experience Epilepsy Research 108 2014 1385 1391
21. J.K. Sake, D. Hebert, J. Isojarvi, P. Doty, M. De Backer, K. Davies, and et al. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs CNS Drugs 24 2010 1055 1068
22. V. Villanueva, E. Lopez-Gomariz, J. Lopez-Trigo, J. Palau, M. Garcia, T. Villarroya, and et al. Rational polytherapy with lacosamide in clinical practice: results of a Spanish cohort analysis RELACOVA Epilepsy Behavior 23 2012 298 304
23. M.A. Rogawski, A. Tofighy, H.S. White, A. Matagne, and C. Wolff Current understanding of the mechanism of action of the antiepileptic drug lacosamide Epilepsy Research 110 2015 189 205